Biosimilar Drug ABP 980 was Found Effective

Sean Harper, Amgen’s executive vice president of research and development said ABP 980 was found as effective Roche’s Herceptin (used to treat a type of early breast cancer) in a late-stage study. Read article here….

Notice: The link provided above connects readers to the full content of the posted article. The URL (internet address) for this link is valid on the posted date; medicarereport.org cannot guarantee the duration of the link’s validity. Also, the opinions expressed in these postings are the viewpoints of the original source and are not explicitly endorsed by AMAC, Inc.; the AMAC Foundation, Inc.; or medicarereport.org.